201 related articles for article (PubMed ID: 25469245)
21. The use of carcinoembryonic antigen levels to predict lung nodule malignancy: a meta-analysis.
Li L; Guo C; Wan JL; Fan QS; Xu XL; Fu YF
Acta Clin Belg; 2022 Feb; 77(1):227-232. PubMed ID: 32703103
[TBL] [Abstract][Full Text] [Related]
22. An elevated CA 19-9 is associated with invasive cancer and worse survival in IPMN.
Ciprani D; Morales-Oyarvide V; Qadan M; Hank T; Weniger M; Harrison JM; Rodrigues C; Horick NK; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Pancreatology; 2020 Jun; 20(4):729-735. PubMed ID: 32332003
[TBL] [Abstract][Full Text] [Related]
23. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
[TBL] [Abstract][Full Text] [Related]
24. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer.
Kim HS; Han Y; Kang JS; Kang YH; Lee M; Sohn HJ; Kim H; Kwon W; Jang JY
BJS Open; 2021 Nov; 5(6):. PubMed ID: 34935900
[TBL] [Abstract][Full Text] [Related]
25. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
26. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy.
Manojlovic N; Savic G; Nikolic B; Rancic N
World J Clin Cases; 2022 Jan; 10(3):899-918. PubMed ID: 35127905
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic yield of endoscopic retrograde cholangiopancreatography-based cytology for distinguishing malignant and benign intraductal papillary mucinous neoplasm: systematic review and meta-analysis.
Suzuki R; Thosani N; Annangi S; Komarraju A; Irisawa A; Ohira H; Obara K; Fleming JB; Guha S; Bhutani MS
Dig Endosc; 2014 Jul; 26(4):586-93. PubMed ID: 24450356
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas.
Ohno R; Kawamoto R; Kanamoto M; Watanabe J; Fujii M; Ohtani H; Harada M; Kumagi T; Kawasaki H
Biomark Insights; 2019; 14():1177271919851505. PubMed ID: 31210727
[TBL] [Abstract][Full Text] [Related]
29. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of CK-19, Galectin-3 and HBME-1 on papillary thyroid carcinoma: a meta-analysis.
Xin Y; Guan D; Meng K; Lv Z; Chen B
Int J Clin Exp Pathol; 2017; 10(8):8130-8140. PubMed ID: 31966665
[TBL] [Abstract][Full Text] [Related]
31. What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses.
Sultana A; Jackson R; Tim G; Bostock E; Psarelli EE; Cox TF; Sutton R; Ghaneh P; Raraty MG; Neoptolemos JP; Halloran CM
Clin Transl Gastroenterol; 2015 Dec; 6(12):e130. PubMed ID: 26658837
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
33. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
Nagashio Y; Hijioka S; Mizuno N; Hara K; Imaoka H; Bhatia V; Niwa Y; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Yamao K
Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668
[TBL] [Abstract][Full Text] [Related]
34. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy.
Heckler M; Michalski CW; Schaefle S; Kaiser J; Büchler MW; Hackert T
Pancreatology; 2017; 17(2):255-262. PubMed ID: 28189431
[TBL] [Abstract][Full Text] [Related]
35. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
Yang Y; Yan S; Tian H; Bao Y
Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
[TBL] [Abstract][Full Text] [Related]
36. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H
Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Gemenetzis G; Bagante F; Griffin JF; Rezaee N; Javed AA; Manos LL; Lennon AM; Wood LD; Hruban RH; Zheng L; Zaheer A; Fishman EK; Ahuja N; Cameron JL; Weiss MJ; He J; Wolfgang CL
Ann Surg; 2017 Aug; 266(2):339-345. PubMed ID: 27631774
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology, Carcinoembryonic Antigen, and Amylase in Intraductal Papillary Mucinous Neoplasm.
Moris M; Raimondo M; Woodward TA; Skinner V; Arcidiacono PG; Petrone MC; De Angelis C; Manfrè S; Fusaroli P; Asbun H; Stauffer J; Wallace MB
Pancreas; 2016 Jul; 45(6):870-5. PubMed ID: 26646270
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms.
Watanabe Y; Niina Y; Nishihara K; Okayama T; Tamiya S; Nakano T
Acta Chir Belg; 2018 Aug; 118(4):239-245. PubMed ID: 29334845
[TBL] [Abstract][Full Text] [Related]
40. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]